Proteomics signs PromarkerD agreement with US big pharma
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- PromarkerD kit version complete- commercial release imminent
- Appendix 4C - September 2018 Quarterly Report
- Diabetic kidney disease test enters Europe & Export Award
- Proteomics receives $834k in R&D Tax Incentive
- Proteomics & Atturos partner to target diagnostics in Europe
Later from Proteomics International Laboratories
- PromarkerD US market update
- Appendix 4C - December 2018 Quarterly Report
- US patent for identifying drugs for abnormal kidney function
- Appendix 4C - March 2019 Quarterly Report
- Proteomics secures contracts for pharmacokinetic analysis
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories